A review of addiction

Postgraduate Medicine

Volumn 120, Issue 2, 2008, Pages

  Clay, Steven W ^a   Allen, Jason ^a   Parran, Theorore ^b  

^a OHIO UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiclive behavior; Addiction; Brain disease; Cocaine related disorders; Opioid related disorders; Substance abuse; Substance related disorders

Indexed keywords

ACAMPROSATE; ALCOHOL; AMFEBUTAMONE; AMPHETAMINE; ARIPIPRAZOLE; BACLOFEN; BUPRENORPHINE; CANNABIS; COCAINE; DISULFIRAM; METHADONE; MODAFINIL; NALTREXONE; NICOTINE; OPIATE; PROPRANOLOL; RIMONABANT; TERGURIDE; TOPIRAMATE; DOPAMINE;

ADDICTION; ALCOHOLISM; ARTICLE; BRAIN DISEASE; COCAINE DEPENDENCE; COGNITIVE THERAPY; DECISION MAKING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; DRUG DETOXIFICATION; ENVIRONMENTAL STRESS; FOLLOW UP; HEREDITY; HEROIN DEPENDENCE; HUMAN; INTERVIEW; LIMBIC SYSTEM; OUTPATIENT; PATIENT CARE; PATIENT REFERRAL; PHYSICIAN; RELAPSE; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; MESENCEPHALON; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR;

BEHAVIOR, ADDICTIVE; DOPAMINE; HUMANS; LIMBIC SYSTEM; MESENCEPHALON; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 54049134887     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2008.07.1802     Document Type: Article

References (25)

1. American Medical Association. Balancing the Response to Prescription Drug Abuse: Report of a National Symposium on Medicine and Public Policy. Chicago, IL: American Medical Association, Department of Substance Abuse; 1990.
2. Johnson TP, Booth AL, Johnson P. Physician beliefs about substance misuse and its treatment: findings from a U.S. survey of primary care practitioners. Subst Use Misuse. 2005;40(8):1071-1084. (Pubitemid 41077339)
3. Lindberg M, Vergara C, Wild-Wesley R, Gruman C. Physicians-in-training attitudes toward caring for and working with patients with alcohol and drug abuse diagnoses. South Med J. 2006;99(1):28-35.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Text Revision. American Psychiatric Association: Chicago, IL; 2000.
5. National Institute on Drug Abuse. NIDA slide teaching packet for scientists. The brain and the actions of cocaine, opiates, and marijuana. Rockville, MD: National Institute on Drug Abuse; 1996.
6. Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev. 2006;30(2):215-238. (Pubitemid 41821810)
7. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol. 1998;12(1):54-67. (Pubitemid 28143000)
8. Vaillant GE. Natural history of addiction and pathways to recovery. In: Graham AW, Schultz TK, Mayo-Smith MF, et al. eds. Principles of Addiction Medicine. 3rd ed. Chevy Chase, MD: American Society of Addiction Medicine; 2003.
9. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet. 2005;6(7):521-532. (Pubitemid 40910429)
10. Connor JP, Young RM, Lawford BR, Ritchie TL. Noble EP. D(2) dopamine receptor (DRD2) polymorphism is associated wilh severity of alcohol dependence. Eur Psychiatry. 2002;17(1):17-23. (Pubitemid 34266301)
11. Saxon AJ, Oreskovich MR, Brkanac Z. Genetic determinants of addiction to opioids and cocaine. Harv Rev Psychiatry. 2005;13(4):218-232. (Pubitemid 41437573)
12. Noble EP, Gottschalk LA, Fallon JH, Ritchie TL, Wu JC. D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet. 1997;74(2):162-166. (Pubitemid 27187645)
13. Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res. 2000;126:325-341. (Pubitemid 35461297)
14. De Bellis MD. Developmental traumatology: a contributory mechanism for alcohol and substance use disorders. Psychoneuroendocrinology. 2002;27(1-2):155-170. (Pubitemid 34028164)
15. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162(8):1403-1413. (Pubitemid 41105554)
16. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: The role of reward-related learning and memory. Annu Rev Neurosci. 2006;29:565-598. (Pubitemid 44476856)
17. Self DW, Nestler EJ. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend. Jun-Jul 1998;51(1-2):49-60. (Pubitemid 28353755)
18. National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide. NIH Publication No. 99-4180. Roekville, MD: National Institute on Drug Abuse; 1999.
19. O'Brien CP. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry. 2005;162(8):1423-1431. (Pubitemid 41105556)
20. Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003;25(3):125-134. (Pubitemid 37518373)
21. Fiellin DA, Reid MC, O'Connor PG. Outpatient management of patients with alcohol problems. Ann Intern Med. 2000;133(10):815-827.
22. Saitz R, Horton NJ, Larson MJ, Winter M, Samet JH. Primary medical care and reductions in addiction severity: a prospective cohort study. Addiction. 2005;100(1):70-78.
23. Prochaska JO. Enhancing motivation to change. In: Graham AW, Schultz TK, et al. eds. Principles of Addiction Medicine. 3rd ed. Chevy Chase. MD: American Society of Addiction Medicine; 2003.
24. Miller WR, Rollnick, S. Motivational Interviewing: Preparing People for Change. 2nd ed. New York, NY: Guilford Press; 2002.
25. Shore JH. The Oregon experience with impaired physicians on probation. An eight-year follow-up. JAMA. 1987;257(21):2931-2934.